Paul Mahon
2012
In 2012, Paul Mahon earned a total compensation of $5.3M as Executive Vice President and General Counsel at United Therapeutics, a 47% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,927,743 |
|---|---|
| Non-Equity Incentive Plan | $416,282 |
| Option Awards | $2,273,625 |
| Salary | $676,900 |
| Other | $14,124 |
| Total | $5,308,674 |
Mahon received $2.3M in option awards, accounting for 43% of the total pay in 2012.
Mahon also received $1.9M of change in pension value and nonqualified deferred compensation earnings, $416.3K in non-equity incentive plan, $676.9K in salary and $14.1K in other compensation.
Rankings
In 2012, Paul Mahon's compensation ranked 1,124th out of 11,487 executives tracked by ExecPay. In other words, Mahon earned more than 90.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,124 out of 11,487 | 90th |
Division Manufacturing | 405 out of 4,253 | 91st |
Major group Chemicals And Allied Products | 93 out of 1,203 | 92nd |
Industry group Drugs | 53 out of 925 | 94th |
Industry Pharmaceutical Preparations | 46 out of 700 | 93rd |
Source: SEC filing on April 30, 2015.
Mahon's colleagues
We found three more compensation records of executives who worked with Paul Mahon at United Therapeutics in 2012.